-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Amneal Pharmaceuticals, Inc. annual/quarterly Current Federal Tax Expense (Benefit) history and growth rate for Q1 2020.
- Amneal Pharmaceuticals, Inc. Current Federal Tax Expense (Benefit) for the quarter ending March 27, 2020 was $110M.
- Amneal Pharmaceuticals, Inc. annual Current Federal Tax Expense (Benefit) for 2023 was $2.47M.
- Amneal Pharmaceuticals, Inc. annual Current Federal Tax Expense (Benefit) for 2022 was -$1.07M, a 182% decline from 2021.
- Amneal Pharmaceuticals, Inc. annual Current Federal Tax Expense (Benefit) for 2021 was $1.31M.
Current Federal Tax Expense (Benefit), Quarterly (USD)